Alignment Healthcare (NASDAQ:ALHC) Shares Gap Down – Time to Sell?

Alignment Healthcare, Inc. (NASDAQ:ALHC) shares gapped down before the market opened on Tuesday . The stock had previously closed at $12.94, but opened at $12.18. Alignment Healthcare shares last traded at $11.2490, with a volume of 2,678,864 shares traded.

Alignment Healthcare News Roundup

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: Unusual options activity showed investors purchasing 19,456 call options—roughly 996% above typical volume—suggesting some traders are positioning for a rebound, although this is speculative and does not confirm improving fundamentals.
• Positive Sentiment: Brokerages continue to give ALHC an overall “Moderate Buy” rating, indicating that some analysts view the sharp decline as potentially excessive. Alignment Healthcare Given Moderate Buy Recommendation
• Neutral Sentiment: CEO John Kao sold 27,400 shares for approximately $356,200 under a pre-arranged Rule 10b5-1 trading plan. The planned nature of the sale reduces its significance as a bearish signal, though his direct ownership declined by 4.43%. SEC Insider Sale Filing
• Negative Sentiment: Investors reacted sharply to comments at the Baird conference, including management’s apparent reluctance to discuss star ratings. Because star ratings can affect Medicare Advantage payments and member enrollment, the lack of visibility increased concerns about Alignment’s outlook. Alignment Falls After Baird Investor Conference
• Negative Sentiment: Coverage highlighted potential Medicare Advantage reform and uncertainty over how new rule changes could affect Alignment’s economics, adding to pressure on the shares. Medicare Advantage Rule Changes
• Negative Sentiment: Several law firms announced or updated investigations into possible securities-law violations following the stock’s steep conference-related decline. These announcements do not establish wrongdoing, but they add reputational and potential litigation risk. Hagens Berman Investigation Update

Analyst Upgrades and Downgrades

ALHC has been the subject of a number of recent research reports. Zacks Research lowered Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 6th. KeyCorp reaffirmed an “overweight” rating on shares of Alignment Healthcare in a report on Wednesday, June 10th. Raymond James Financial lowered Alignment Healthcare from a “strong-buy” rating to an “outperform” rating and dropped their target price for the stock from $22.00 to $19.00 in a report on Monday, August 3rd. Barclays reduced their price target on Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 26th. Finally, TD Cowen reissued a “buy” rating on shares of Alignment Healthcare in a report on Wednesday. Seven analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat, Alignment Healthcare has a consensus rating of “Moderate Buy” and an average price target of $23.60.

Alignment Healthcare Stock Performance

The company has a debt-to-equity ratio of 1.22, a quick ratio of 1.70 and a current ratio of 1.70. The firm has a market capitalization of $1.81 billion, a PE ratio of 45.84 and a beta of 1.11. The firm’s 50 day moving average price is $15.44 and its 200-day moving average price is $17.82.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Thursday, July 30th. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.04. Alignment Healthcare had a return on equity of 20.02% and a net margin of 0.89%.The firm had revenue of $1.34 billion during the quarter, compared to analyst estimates of $1.31 billion. During the same quarter in the previous year, the business earned $0.07 EPS. Alignment Healthcare’s revenue for the quarter was up 31.6% compared to the same quarter last year. On average, research analysts expect that Alignment Healthcare, Inc. will post 0.17 EPS for the current year.

Insider Transactions at Alignment Healthcare

In related news, EVP Joseph S. Konowiecki sold 25,000 shares of the business’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $24.00, for a total value of $600,000.00. Following the completion of the sale, the executive vice president owned 1,103,816 shares of the company’s stock, valued at approximately $26,491,584. The trade was a 2.21% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Dawn Maroney sold 122,707 shares of the company’s stock in a transaction on Friday, September 11th. The stock was sold at an average price of $12.68, for a total transaction of $1,555,924.76. Following the transaction, the president owned 794,606 shares of the company’s stock, valued at $10,075,604.08. This represents a 13.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 1,353,977 shares of company stock valued at $20,263,764 in the last three months. 5.20% of the stock is currently owned by company insiders.

Institutional Trading of Alignment Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Wellington Management Group LLP lifted its stake in Alignment Healthcare by 9.8% in the 2nd quarter. Wellington Management Group LLP now owns 18,780,363 shares of the company’s stock valued at $447,160,000 after buying an additional 1,681,427 shares in the last quarter. William Blair Investment Management LLC purchased a new stake in Alignment Healthcare during the 2nd quarter worth approximately $184,799,000. Geode Capital Management LLC increased its stake in Alignment Healthcare by 8.4% during the 4th quarter. Geode Capital Management LLC now owns 3,841,703 shares of the company’s stock worth $75,884,000 after buying an additional 299,279 shares in the last quarter. Danica Pension Livsforsikringsaktieselskab acquired a new position in shares of Alignment Healthcare during the second quarter valued at approximately $87,794,000. Finally, Bank of New York Mellon Corp acquired a new position in shares of Alignment Healthcare during the second quarter valued at approximately $87,077,000. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc is a technology-enabled healthcare company that provides Medicare Advantage health plans and care-management services for older adults. Through its Alignment Health Plan subsidiary, the company offers insurance coverage designed for Medicare-eligible members, including primary and specialty care coordination, prescription drug benefits, preventive services and access to a network of healthcare providers.

The company combines health-plan operations with proprietary technology intended to support personalized care.